Ann: Appendix 4C - quarterly, page-5

Medigard has some 650 shareholders. Most would have appreciated a commentary attached to the latest quarterly 4c, would they not?

There was none.

Directors could have given us an update on the recently-formed Medical Advisory Panel. Who are the members? What are they doing?

And they could have offered an update as to what's happening with the partnership with Sol Millennium Medical HK. Sol Millenium holds some $560k in convertible notes. These are due in eight months.

And what about a comment on the 90% fall in Q3 receipts to virtually nothing. And the 40% surge in cash burn to $94k?

And an explanation as to why the cash burn was less than half the $190k estimate made just three months ago?

My plea to chairman Dr Chris Bishop and ED Dr Ian Dixon: Speak to us.